• Sulfo-NHS-SS-Biotin: Precision Cell Surface Protein Labeling

  2026-05-20

  Unlock high-fidelity, reversible protein and antibody biotinylation with the Sulfo-NHS-SS-Biotin Kit. Its unique chemistry empowers selective, artifact-free cell surface labeling and dynamic interactome analysis—streamlining workflows in proteomics, affinity purification, and advanced cell biology.

• YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol: Techn

  2026-05-20

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is a research-grade sGC activator and post-transcriptional HIF-1α inhibitor used to study hypoxia signaling, angiogenesis, and apoptosis in cancer models. This compound is best suited for controlled in vitro and in vivo assays where precise modulation of hypoxia-inducible factor 1 transcriptional activity is required. It is not recommended for diagnostic or clinical applications due to its research-only specification.

• FITC Goat Anti-Mouse IgG (H+L) Antibody: Precision in Immuno

  2026-05-19

  The FITC Goat Anti-Mouse IgG (H+L) Antibody delivers robust, amplified signal and high specificity for mouse IgG detection in cutting-edge immunofluorescence and flow cytometry. Discover workflow refinements, troubleshooting tactics, and how recent antiviral research informs antibody-based assay optimization.

• EPZ-6438 and EZH2 Inhibition: Advancing Epigenetic Cancer Mo

  2026-05-19

  Explore how EPZ-6438, a potent EZH2 inhibitor, is revolutionizing epigenetic cancer research through innovative assay integration and insights from combinational therapy studies. Discover practical guidance for experimental design that goes beyond standard protocols.

• Temafloxacin: Fluoroquinolone Broad-Spectrum Antibacterial A

  2026-05-18

  Temafloxacin stands out as a fluoroquinolone broad-spectrum antibacterial agent, delivering potent, reproducible results in both in vitro and in vivo infection models. This article details actionable workflows, data-driven protocol enhancements, and troubleshooting strategies for optimal laboratory application—empowering researchers to confidently address Gram-positive, Gram-negative, and intracellular pathogens.

• ELP-Delivered p21 Peptide Suppresses Glioblastoma Proliferat

  2026-05-18

  This study demonstrates that elastin-like polypeptide (ELP)-mediated delivery of a p21-derived cell cycle inhibitory peptide enables efficient intracellular uptake and cytostatic suppression of glioblastoma cell proliferation. The innovation lies in overcoming delivery barriers to peptide therapeutics for brain tumors, with implications for developing targeted, non-apoptotic anti-cancer strategies.

• miR-4769-3p Regulates Adipogenesis in Systemic Sclerosis Mod

  2026-05-17

  Tang et al. (2024) reveal that miR-4769-3p is upregulated in systemic sclerosis (SSc) and directly suppresses adipogenesis through negative regulation of the USP18/VDAC2 pathway. Their work elucidates a crucial axis linking microRNA activity to adipose tissue loss and fibrosis in SSc, with implications for disease modeling and therapeutic targeting.

• Cy3-UTP: Precision RNA Labeling for Advanced Interaction Stu

  2026-05-16

  Cy3-UTP empowers researchers to achieve high-sensitivity, photostable RNA labeling for in vitro transcription and interaction studies. This guide translates recent mechanistic insights into actionable protocols, troubleshooting advice, and comparative advantages—enabling robust fluorescence imaging and RNA-protein assays with confidence.

• Cy5 NHS ester(Et): Technical Guide for Protein Labeling Work

  2026-05-15

  Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of primary amines in proteins and other biomolecules for applications like immunofluorescence and flow cytometry. It is not suitable for ethanol-based protocols or for long-term storage of dissolved working solutions. Use is recommended only within validated aqueous or DMSO labeling workflows.

• SP2509: Precision Lysine-Specific Demethylase 1 Antagonist i

  2026-05-15

  SP2509 is redefining AML research as a potent Lysine-specific demethylase 1 antagonist, enabling robust apoptosis induction and differentiation workflows. Its selectivity, stability, and compatibility with epigenetic co-therapies position it as an essential tool for dissecting cancer epigenetics and enhancing reproducibility in challenging cell models.

• AT-406 (SM-406): Optimizing Apoptosis Pathway Activation in

  2026-05-14

  AT-406 (SM-406) stands out as a potent, orally bioavailable IAP antagonist, enabling robust apoptosis pathway activation and chemosensitization in preclinical cancer models. This guide delivers actionable workflow enhancements, troubleshooting strategies, and context from recent structural breakthroughs to help researchers unlock the full translational impact of AT-406 in oncology research.

• Moxidectin: Macrocyclic Lactone Anthelmintic for Antifungal

  2026-05-14

  Moxidectin, a macrocyclic lactone anthelmintic, now drives new antifungal workflows by synergizing with polyenes to suppress Candida albicans. This guide translates breakthrough research into robust, optimized protocols for biomedical laboratories seeking reliable antifungal synergy.

• 8-Chloroadenosine (SKU B7667): Reliable Nucleoside Analog fo

  2026-05-13

  This evidence-based article explores how 8-Chloroadenosine (SKU B7667) addresses persistent challenges in RNA synthesis inhibition, cell viability, and transcriptional regulation research. Drawing on recent cancer research and validated best practices, we outline scenario-driven solutions for biomedical scientists seeking reproducible, high-purity nucleoside analogs. APExBIO’s formulation is examined for its performance, solubility, and workflow compatibility.

• IR-1061: Optimizing Near Infrared Fluorescent Dye for In Viv

  2026-05-13

  IR-1061 from APExBIO transforms in vivo deep tissue imaging by leveraging its superior NIR-II fluorescence and optimal liposomal encapsulation strategies. This guide translates frontier research into protocol-ready workflows, troubleshooting, and comparative application insights for biomedical imaging teams.

• Mitochondrial Apoptosis and Muscle Atrophy in Ovarian Cancer

  2026-05-12

  This study explores the mechanistic relationship between mitochondrial-derived reactive oxygen species (ROS), apoptotic and necroptotic signaling, and skeletal muscle atrophy in a mouse model of metastatic ovarian cancer. The authors demonstrate that while SkQ1, a mitochondrial-targeted antioxidant, attenuates mitochondrial-linked apoptotic caspase activity, it does not prevent muscle atrophy, challenging assumptions about the causality between these pathways and muscle wasting.

16225 records 1/1082 page Next 12345 下5页 Last page